Werewolf Therapeutics Inc.
HOWL | NASDAQ
$0.98
$0 (0.00%)
Sep 22, 2026, 10:24 AM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
PE Ratio | -0.48 | -0.91 | -3.68 | -1.10 | -1.09 | -16.43 |
PEG Ratio | 0.03 | -0.02 | 0.08 | 0.01 | 0 | -0.10 |
PS Ratio | n/a | 34.02 | 6.90 | 3.61 | n/a | n/a |
PB Ratio | 1.18 | 0.87 | 1.24 | 0.48 | 1.44 | 5.17 |
P/FCF Ratio | -0.48 | -1.14 | -4.12 | -1.34 | -5.07 | -24.06 |
P/OCF Ratio | -0.48 | -1.14 | -4.22 | -1.46 | -5.13 | -24.78 |
OCF/S Ratio | n/a | -2.98K | -163.53 | -247.52 | n/a | n/a |
Debt / Equity Ratio | 0.38 | 0.51 | 0.47 | 0.12 | 0.10 | 0.03 |
Quick Ratio | 1.62 | 7.45 | 7.14 | 5.84 | 13.56 | 17.58 |
Current Ratio | 1.62 | 7.45 | 7.14 | 5.84 | 13.56 | 17.58 |
Asset Turnover | n/a | 0.01 | 0.11 | 0.10 | n/a | n/a |
Interest Coverage | -11.50 | -15.81 | -12.90 | n/a | n/a | n/a |
Return on Equity | -245.20% | -96.08% | -33.55% | -43.99% | -32.71% | -16.74% |
Return on Assets | -87.64% | -55.55% | -21.37% | -33.58% | -27.88% | -15.50% |
Return on Invested Capital | -173.37% | -64.95% | -24.74% | -40.52% | -29.73% | -24.41% |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | n/a | 3.77% | 91.15% | 84.70% | n/a | n/a |
Net Profit Margin | n/a | -3.74K% | -187.37% | -328.09% | n/a | n/a |
Pretax Profit Margin | n/a | -3.74K% | -187.37% | -328.09% | n/a | n/a |
Operating Profit Margin | n/a | -3.9K% | -203.09% | -341.78% | n/a | n/a |
FCF Margin | n/a | -2.99K% | -167.38% | -269.54% | n/a | n/a |
EBITDA Margin | n/a | -3.4K% | -162.79% | -312.79% | n/a | n/a |
Add to Watchlist
Select watchlists to add or remove HOWL